ОбзорГрафикНовостиTraderScreen

Goldman Sachs Knock-Out KLAC/  DE000GG2TMJ7  /

EUWAX
14.05.2024  11:00:09 Изменение+0.19 Бид13:28:13 Предложение13:28:13 Базовый актив Цена исполнения Дата истечения Тип опциона
12.28EUR +1.57% 12.18
Величина цены спроса: 500		 12.38
Величина цены предложения: 500		 KLA Corporation 582.9987 USD 31.12.2078 Call
TeleTrader 13:42 Turkey to file application to join case against Israel
GlobeNewswire 13:35 Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
TeleTrader 13:32 GameStop skyrockets 120% as meme stock rally goes on
TeleTrader 13:30 China outraged over higher US tariffs
GlobeNewswire 13:30 Kroma Announces Spectrum’s Launch Alongside Expansion Plans
GlobeNewswire 13:30 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 13:30 MiNK Reports First Quarter 2024 Results
GlobeNewswire 13:30 Alimera Sciences Reports First Quarter 2024 Results
GlobeNewswire 13:30 Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire 13:30 ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire 13:30 Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire 13:30 Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire 13:30 Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire 13:30 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 13:30 FitLife Brands Announces First Quarter 2024 Results
GlobeNewswire 13:30 BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire 13:30 Batteh Named Saia’s Chief Financial Officer
GlobeNewswire 13:30 XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire 13:30 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 13:30 Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
GlobeNewswire 13:30 HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio
GlobeNewswire 13:30 Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
GlobeNewswire 13:30 Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
GlobeNewswire 13:30 nCino Announces Timing of its First Quarter Fiscal Year 2025 Financial Results Conference Call
GlobeNewswire 13:30 2024 Rabbet Report: Risk Management and Automation Emerge as Top Priorities in Construction Finance